These FDA-Approved Drugs and Vaccines Were “Most Influential” in 2024: GoodRx
2024 brought significant things advances in medicine.
These include the approval of “innovative” drugs such as Tryvio for high blood pressure, Neffy for severe allergic reactions and Dupixent for chronic obstructive pulmonary disease (COPD), all of which received FDA approval this year.
These drugs “are predicted to have major clinical impact for those who need them,” according to GoodRx, a California-based digital healthcare platform.
WHAT ARE PRESCRIPTION DRUGS NAMED? DRUG DEVELOPMENT EXPERT SHARES THE PROCESS
Earlier this month, GoodRx released a list of the 19 most influential drugs and approval of vaccines of 2024, some newly developed treatments for certain conditions and other existing drugs that are approved for additional use.
Here is a list by FDA approval date.
1. Dupixent – Additional use: Eosinophilic esophagitis (an allergic disease that causes inflammation of the esophagus)
2. Amtagvi – New medicine: Advanced melanoma
3. Xolair – Additional use: Food allergies
GOOGLE’S 7 MOST SEARCHED HEALTH QUESTIONS IN 2024 WITH EXPERT ANSWERS
4. Wegovy – Additional use: Reduction of cardiovascular risk
5. I tried – New medicine: High blood pressure
6. Nexletol – Additional use: High cholesterol
7. Winrevair – New drug: Pulmonary arterial hypertension
8. mRESVIA – New vaccine: RSV
9. Capvaxive – New vaccine: Pneumococcal disease
10. Wakix – Additional use: Pediatric narcolepsy
5 MAIN ALZHEIMER’S DISCOVERIES MADE BY SCIENTISTS IN 2024.
11. Ohtuvayre – New drug: COPD
12. Kisunla – New drug: Alzheimer’s disease
13. Voquezna – Additional use: Heartburn from non-erosive GERD (gastroesophageal reflux disease)
14. Zunveyl – New medicine: Alzheimer’s disease
15. Yorvipath – New drug: Hypoparathyroidism (low level of parathyroid hormone)
For more health articles visit www.foxnews.com/health
16. Neffy – New medicine: Difficult allergic reactions
17. FluMist – Additional use: self-administration or administration by a caregiver
CLICK HERE TO SUBSCRIBE FOR OUR HEALTH NEWSLETTER
18. Cobenfy – New drug: Schizophrenia
19. Dupixent – Additional use: COPD
In a disclaimer, GoodRx said the list was created by prioritizing “the first drugs and vaccines expected to have a significant impact on human health.”
“This is defined as either the number of lives affected or the expected degree of impact for future recipients of the drugs,” the company wrote.
“We also prioritized drugs with efficacy or safety data that represented a significant advantage over other drugs recommended by clinical treatment guidelines or major medical organizations.”
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
Fox News Digital has reached out to GoodRx for comment.